Drug Details
Itacitinib is a novel and selective JAK1 inhibitor.
Study Purpose
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of itacitinib in participants with post-lung transplant bronchiolitis obliterans syndrome (BOS).
